MRKR · Categories · Form 4

MRKR - SEC Form 4 insider transactions

Marker Therapeutics Inc. (MRKR) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for MRKR

• 212d
  SEC Form 4 filed by Director Knobil Katharine

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 212d
  SEC Form 4 filed by Director Eansor Norman David

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 212d
  SEC Form 4 filed by Director Elms Steve

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 227d
  SEC Form 4 filed by Director Corzo Kathryn Penkus

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 227d
  SEC Form 4 filed by Chief Executive Officer Vera Juan

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 490d
  SEC Form 4 filed by Director Elms Steve

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 490d
  SEC Form 4 filed by Director Knobil Katharine

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 490d
  SEC Form 4 filed by Director Eansor Norman David

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 490d
  SEC Form 4 filed by President and CEO Vera Juan

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1107d
  SEC Form 4 filed by Eansor Norman David

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1107d
  SEC Form 4 filed by Knobil Katharine

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1107d
  SEC Form 4 filed by Wilson John Robert

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1107d
  SEC Form 4 filed by Elms Steve

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1135d
  SEC Form 4 filed by Vera Juan

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1206d
  SEC Form 4 filed by Hoang Tsvetelina P

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1206d
  SEC Form 4 filed by Koneru Mythili

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1206d
  SEC Form 4 filed by Vera Juan

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1206d
  SEC Form 4 filed by Loiacono Michael

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1206d
  SEC Form 4 filed by Szymanska Anna

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1206d
  SEC Form 4 filed by Agopyan Nadia

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1485d
  SEC Form 4 filed by Elms Steve

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1485d
  SEC Form 4 filed by Wilson John Robert

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1485d
  SEC Form 4 filed by Laskow-Pooley David

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1485d
  SEC Form 4 filed by Eansor Norman David

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1485d
  SEC Form 4 filed by Knobil Katharine

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1544d
  SEC Form 4: Hoang Peter L. was granted 199,094 shares and covered exercise/tax liability with 48,376 shares, increasing direct ownership by 45% to 483,286 units to satisfy tax liability

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1544d
  SEC Form 4: Vera Juan was granted 140,823 shares and covered exercise/tax liability with 33,465 shares, increasing direct ownership by 4% to 2,671,845 units (withholding obligation)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1544d
  SEC Form 4: Kim Anthony H. was granted 150,512 shares and covered exercise/tax liability with 36,076 shares to satisfy withholding tax

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Hoang Peter L.

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Szymanska Anna

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Vera Juan

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Koneru Mythili

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Loiacono Michael

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Kim Anthony H.

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Hoang Tsvetelina P

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Garrett Gerald

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Agopyan Nadia

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1653d
  SEC Form 4 filed by Knobil Katharine

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1835d
  SEC Form 4: Wasserman Frederick Gerald was granted 12,658 units of Common Stock, increasing direct ownership by 24% to 65,223 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1835d
  SEC Form 4: Laskow-Pooley David was granted 12,658 units of Common Stock, increasing direct ownership by 30% to 55,223 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1835d
  SEC Form 4: ELMS STEVE was granted 12,658 units of Common Stock, increasing direct ownership by 74% to 29,680 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1835d
  SEC Form 4: Eansor Norman David was granted 12,658 units of Common Stock, increasing direct ownership by 52% to 36,940 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1835d
  SEC Form 4: Wilson John Robert was granted 12,658 units of Common Stock, increasing direct ownership by 0.16% to 7,812,008 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1856d
  SEC Form 4: Wasserman Frederick Gerald bought $24,098 worth of Common Stock (10,000 units at $2.41), increasing direct ownership by 23% to 52,565 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Edward Paul Walker bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: W. Peter Sonsini bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: D Scott Sandell bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Joshua Makower bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Mohamad Makhzoumi bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Jr. A. Anthony Florence bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Carmen Chang bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Ali Behbahani bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Forest Baskett bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: L.P. 16, Associates Enterprise New bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Robert John Wilson bought $2,999,999 worth of Common Stock (1,714,285 units at $1.75), increasing direct ownership by 28% to 7,799,350 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Juan Vera bought $999,999 worth of Common Stock (571,428 units at $1.75), increasing direct ownership by 29% to 2,564,487 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: L. Peter Hoang bought $250,000 worth of Common Stock (142,857 units at $1.75), increasing direct ownership by 75% to 332,568 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Steve Elms bought $2,000,000 worth of Common Stock (1,142,857 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1941d
  SEC Form 4 filed by M. Ann Leen

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1953d
  SEC Form 4 filed by Juan Vera

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)

Other MRKR categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends